TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial

A. J. M. van de Sande; M. M. Koeneman; C. G. Gerestein; A. J. Kruse; F. J. van Kemenade; H. J. van Beekhuizen

doi:10.1186/s12885-018-4510-7

TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial

A. J. M. van de Sande^*, M. M. Koeneman, C. G. Gerestein, A. J. Kruse, F. J. van Kemenade, H. J. van Beekhuizen

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	655
Number of pages	6
Journal	BMC Cancer
Volume	18
DOIs	https://doi.org/10.1186/s12885-018-4510-7
Publication status	Published - 15 Jun 2018

Keywords

Cervical intraepithelial neoplasia
Imiquimod
Human papillomavirus
Quality of life
Dysplasia cervix
LLETZ
Transformation zone
ELECTROSURGICAL EXCISION PROCEDURE
PREGNANCY OUTCOMES
RISK
METAANALYSIS
CONIZATION
DISEASE
BIRTH
LEEP

Access to Document

10.1186/s12885-018-4510-7

https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-018-4510-7

Cite this

@article{8bc3113ba1ad4d03a25e6d646a03c078,

title = "TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial",

keywords = "Cervical intraepithelial neoplasia, Imiquimod, Human papillomavirus, Quality of life, Dysplasia cervix, LLETZ, Transformation zone, ELECTROSURGICAL EXCISION PROCEDURE, PREGNANCY OUTCOMES, RISK, METAANALYSIS, CONIZATION, DISEASE, BIRTH, LEEP",

author = "{van de Sande}, {A. J. M.} and Koeneman, {M. M.} and Gerestein, {C. G.} and Kruse, {A. J.} and {van Kemenade}, {F. J.} and {van Beekhuizen}, {H. J.}",

year = "2018",

month = jun,

day = "15",

doi = "10.1186/s12885-018-4510-7",

language = "English",

volume = "18",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "BioMed Central Ltd",

}

TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial. / van de Sande, A. J. M.; Koeneman, M. M.; Gerestein, C. G.; Kruse, A. J.; van Kemenade, F. J.; van Beekhuizen, H. J.

In: BMC Cancer, Vol. 18, 655, 15.06.2018.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial

AU - van de Sande, A. J. M.

AU - Koeneman, M. M.

AU - Gerestein, C. G.

AU - Kruse, A. J.

AU - van Kemenade, F. J.

AU - van Beekhuizen, H. J.

PY - 2018/6/15

Y1 - 2018/6/15

KW - Cervical intraepithelial neoplasia

KW - Imiquimod

KW - Human papillomavirus

KW - Quality of life

KW - Dysplasia cervix

KW - LLETZ

KW - Transformation zone

KW - ELECTROSURGICAL EXCISION PROCEDURE

KW - PREGNANCY OUTCOMES

KW - RISK

KW - METAANALYSIS

KW - CONIZATION

KW - DISEASE

KW - BIRTH

KW - LEEP

U2 - 10.1186/s12885-018-4510-7

DO - 10.1186/s12885-018-4510-7

M3 - Article

C2 - 29902979

VL - 18

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 655

ER -